Collaborations to Enhance Drug Development and Regulatory Science
The FDA is offering cooperative agreement funding to support public-private partnership collaborations focused on regulatory science and drug development. Funded efforts will be identified around priority needs to accelerate drug product development, advance manufacturing, translate basic research into therapies, and improve the safety, efficacy, quality, and performance of drug products, with…
Source
Award
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
National Institutes of Health
-
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
Food and Drug Administration
-
Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)
National Institutes of Health
-
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
National Institutes of Health
-
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers